Search

everythinglearnresearchcommunity

for

Search:↓

The combined therapy improved fertility in women with PCOS, especially in certain types.

Testosterone and finasteride raise insulin and zinc, lower chromium in male rats.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

Metformin and clomiphene citrate together improve pregnancy chances and reduce miscarriages in women with PCOS.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Finasteride effectively increases hair growth in men with AGA, works better for those over 30, and may cause some side effects.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

A man's fertility improved after he stopped taking finasteride but worsened again when he restarted the medication.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Finasteride may negatively affect male fertility.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Finasteride 1-mg doesn't harm sperm or pregnancy chances.

The entry showed that PCOS negatively affects women's self-image and is worsened by societal expectations, suggesting a need for more feminist attention to the condition.

Hair loss doesn't affect COVID-19 severity.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

Skin issues are common and important for diagnosing PCOS.

PCOS has many symptoms, with high androgen levels being the most common.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.